J Biol Chem, Vol. 273, Issue 28, 17585-17594, July 10, 1998
Differential Interactions of the C terminus and the Cytoplasmic
I-II Loop of Neuronal Ca2+ Channels with G-protein
and

Subunits
I. MOLECULAR DETERMINATION*
Taiji
Furukawa
§,
Toshihide
Nukada
¶,
Yasuo
Mori
**,
Minoru
Wakamori
**,
Yoshihiko
Fujita
,
Hiroyuki
Ishida
,
Kazuhiko
Fukuda§§,
Shigehisa
Kato§§, and
Mitsunobu
Yoshii¶¶
From the
Department of Neurochemistry and
¶¶ Department of Neurophysiology, Tokyo Institute of
Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156, the
§ Department of Internal Medicine, Faculty of Medicine,
Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 173, the
Department of Information Physiology, National Institute for
Physiological Sciences, Okazaki, Aichi 444, Japan, the ** Institute of
Molecular Pharmacology and Biophysics, University of Cincinnati College
of Medicine, Cincinnati, Ohio 45267-0828, and the

Department of Molecular Genetics, Kyoto
University Faculty of Medicine, Yoshidakonoe-cho and
§§ Department of Anesthesia, Kyoto University
Hospital, 54 Shogoin-Kawaharacho, Sakyo-ku,
Kyoto 606-01, Japan
 |
ABSTRACT |
Interactions of G-protein
(G
) and 
subunits (G
) with N- (
1B) and P/Q-type
(
1A) Ca2+ channels were investigated using
the Xenopus oocyte expression system. Gi3
was found to inhibit both N- and P/Q-type channels by receptor
agonists, whereas G
1
2 was responsible for
prepulse facilitation of N-type channels. L-type channels
(
1C) were not regulated by G
or G
. For N-type,
prepulse facilitation mediated via G
was impaired when the
cytoplasmic I-II loop (loop 1) was deleted or replaced with the
1C loop 1. G
-mediated inhibitions were also impaired
by substitution of the
1C loop 1, but only when the C
terminus was deleted. For P/Q-type, by contrast, deletion of the C
terminus alone diminished G
-mediated inhibition. Moreover, a chimera
of L-type with the
1B loop 1 gained
G
-dependent facilitation, whereas an L-type chimera
with the N- or P/Q-type C terminus gained G
-mediated inhibition.
These findings provide evidence that loop 1 of N-type channels is a
regulatory site for G
and the C termini of P/Q- and N-types for
G
.
 |
INTRODUCTION |
A family of membrane-associated guanine nucleotide-binding
regulatory proteins
(G-proteins)1 is essential
for mediating signal transduction between cell-surface receptors and
intracellular effectors such as adenylate cyclase, phospholipase C,
phospholipase A2, and ion channels (1-4). G-proteins are
composed of three subunits termed
,
, and
. The
subunit (G
) contains a binding site for guanine nucleotides and possesses GTPase activity. Upon receptor stimulation, heterotrimeric G-proteins disassociate into an
-GTP complex and
/
dimer. In most
systems, a GTP-bound G
activates or inhibits an effector system, and
the functional half-life is determined by the intrinsic GTPase activity of G
. Recently, it has been shown that the 
dimer (G
) is significantly important in signal transduction as well (3).
High voltage-activated (HVA) Ca2+ channels are negatively
regulated by G-proteins in a membrane-delimited manner (2, 4). This
response is primarily mediated by pertussis toxin-sensitive G-proteins
(Go/Gi), in which Go
has been
shown to inhibit current from HVA Ca2+ channels (5-7).
Additionally, it has been shown that G
also transduces an
inhibitory signal to HVA Ca2+ channels (8, 9). It remains
to be determined, however, which subunit arm of the G-protein complex
preferentially interacts with N- and P/Q-types of HVA Ca2+
channels. Recently, it has been determined that the intracellular loop
joining motif I and II (referred to as "loop 1" in the present study) is an interaction site on neuronal HVA Ca2+ channels
for G
(10-13). Nevertheless, mapping of region(s) on HVA
Ca2+ channels responsible for interactions with G
and/or
G
is still very incomplete (14).
To address these issues at the molecular level, we have functionally
expressed
1A,
1B, and
1C
of HVA Ca2+ channels in Xenopus oocytes. These
subunits were derived from rabbit brain N-type, P/Q-type, and cardiac
L-type Ca2+ channels, respectively. In addition, we have
co-expressed
-opioid receptor (DOR) together with G
or G
as
we did in determining a region of the muscarinic-gated K+
channel critical for activation by G
with the presumption that co-expression with G
or G
determines which kind of modulation takes place (15). In this paper, interactions of G
and G
with
Ca2+ channels were characterized using mutant and chimeric
N- (
1B) and P/Q-type (
1A)
Ca2+ channels. The results, together with evidence for a
direct binding provided by the companion paper (16), define the
interaction sites of Ca2+ channels for G
and
G
.
 |
EXPERIMENTAL PROCEDURES |
In Vitro Transcription
The 1.4-kb ApaI/ApaI and 6.8-kb
HindIII/HindIII fragment containing the entire
coding regions of DOR (17) and the Ca2+ channel
1C subunit (18) were inserted into the
HindIII site of the pSPA2 vector (19), to yield pSPDOR and
pSPCDR, respectively. The plasmid pSPCDR was digested with
XbaI, blunted with T4 DNA polymerase, and ligated with a
SalI linker to yield pSPCDRS. The
1C subunit
cDNA was kindly provided by Drs. Atsushi Mikami and Tsutomu Tanabe.
The pSPA1, pSPA2, pSP72, pSP65, and pSP64 recombinant plasmids carrying
the entire protein-coding sequences of Gi3
, G
1, G
2, and Ca2+ channel
1B,
1A,
2, and
1a subunits were described previously (15, 18-21).
Nucleotide sequence analyses revealed that the deduced amino acid
sequence of Gi3
was the same as that reported (22) except that Ser-16, Asp-64, Ser-165, Glu-261, and Pro-282 were determined as Thr (ACG), Glu (GAA), Thr (ACC), Asp (GAC), and Ser
(TCA), respectively, in our clone, pG3
1 (15).
cRNAs specific for
1A,
1B,
1C,
2, and
1a subunits of
the Ca2+ channel, 17 kinds of mutants and chimeric
1 subunits (see below), DOR, Gi3
,
G
1, and G
2 were synthesized in
vitro using a MEGAscript SP6 kit (Ambion).
Construction of Mutant and Chimeric Ca2+ Channels
B3T
1--
The plasmid pSPB3 carrying the entire
protein-coding sequences of
1B (21) was digested with
BamHI and circularized with T4 DNA ligase to
yield pSPB3BH. The 5.5-kb NotI/SrfI fragment excised from pSPB3BH was ligated with the 55-bp
NotI/BglI fragment from pSPB3 and the annealed
oligodeoxyribonucleotides, GGGCTGGCGGTCC and GGACCGCCAGCCCCGC. The
1.7-kb NotI/PflMI fragment from the resulting
plasmid was ligated with the 8.6-kb NotI/PflMI
fragment from pSPB3 to obtain pSPB3S. The plasmid pSPB3S was digested
with SrfI and SpeI, blunted with T4
DNA polymerase, and ligated with the annealed oligonucleotides,
GGGCTTAGCTGCGGAGAAGAGTTCTGAGACGTGCACCGGTT and
AACCGGTGCACGTCTCAGAACTCTTCTCCGCAGCTAAGCCC, to yield pSPB3T
1. In this plasmid, the codon TTC for Tyr-1913 was replaced with the codon
TAG for termination.
B3TCD--
The 8.7-kb SrfI/SalI fragment
excised from pSPB3S was ligated with the 2.2-kb
ScaI/SalI fragment from pSPCDRS to obtain
pSPB3TCD. In this plasmid, the codon CGG for Arg-1911 of the
1B subunit was replaced with the codon CAC for (His),
and the segment encoding amino acid residues 1658-2171 of the
1C subunit was substituted for amino acid residues
1912-2339 of the
1B subunit.
B3LCD and B3LCDT
1--
The plasmid pSPB3S was digested with
EcoRI, blunted, and circularized to delete the
EcoRI site. The resulting plasmid and the plasmid pSPB3T
1
were digested with BsmI, blunted, and ligated with the
EcoRI linker, dGGAATTCC, to produce pSPB3S.E. and
pSPB3T
1E. The plasmids pSPB3S.E. and pSPB3T
1E were digested with
PmlI and EcoRI, and the 9.3-kb
PmlI/EcoRI fragment from pSPB3S.E. or the 7.8-kb
PmlI/EcoRI fragment from pSPB3T
1E was ligated
with the 950-bp BamHI/EcoRI fragment from pSPCDR
and the annealed oligonucleotides, GTGGCCCTGGGTGTATTTTGTCAGTCTGGTCATCTTTG and
GATCCAAAGATGACCAGACTGACAAAATACACCCAGGGCCAC, to yield
pSPB3LCD or pSPB3LCDT
1. In these plasmids, the segment encoding amino acid residues 411-740 of the
1C subunit
was substituted for amino acid residues 332-668 of the
1B subunit.
B3LCDTCD--
The 8.6-kb SrfI/SalI
fragment was excised from pSPB3LCD and ligated with the 2.2-kb
ScaI/SalI fragment from pSPCDRS to yield pSPB3LCDTCD.
CDT
1--
The plasmid pSPCDR was partially digested with
AvrII, blunted with T4 DNA polymerase, and
circularized with T4 DNA ligase to obtain pSPCDTD1. In this
plasmid, the codon AGG and CCC for Arg-1980 and Pro-1981 of the
1C subunit was replaced with the codon AGC (Ser) and TAG
for termination.
CDTB3--
The 5.2-kb HindIII/ScaI and the
3.0-kb HindIII/SalI fragments excised from
pSPCDRS were ligated with the 1.6-kb SrfI/SalI fragment from pSPB3 to obtain pSPCDTB3. In this plasmid, the segment encoding amino acid residues 1912-2339 of the
1B
subunit was substituted for amino acid residues of 1658-2171 of the
1C subunit, and the codon TAC for Tyr-1657 of the
1C subunit was replaced with the codon TGG (Trp).
CDLB3 and CDLB3TB3--
To delete an internal SacI
site, the plasmids pSPCDRS and pSPCDTB3 were partially digested with
SacI, blunted, and circularized to produce pSPCDRSS and
pSPCDTB3S. Another SacI site on pSPCDRSS was deleted by the
same procedure. The resulting plasmid and the plasmid pSPCDTB3S were
digested with SacI and StuI and blunted. The
9.5-kb SacI/StuI fragment from the former or the
8.9-kb SacI/StuI fragment from the latter was
ligated with the 890-bp XhoI/ApaI fragment that
was excised from pSPB3 and blunted with T4 DNA polymerase, in order to yield pSPCDLB3 or pSPCDLB3TB3. In these plasmids, the
segment encoding amino acid residues 242-537 of the
1B
subunit were substituted for amino acid residues 318-610 of the
1C subunit, and the codon CTC for Leu-242 of the
1B subunit and CAG for Gln-611 of the
1C
subunit were replaced with the codon GTC for (Val) and GAG for (Glu),
respectively.
B3L
1--
The 9.6-kb PmlI/PflMI
fragment from pSPB3S was ligated with the 99-bp
PmlI/HhaI and 610-bp
KpnI/PflMI fragments excised from pSPB3 and the
annealed oligonucleotides, CGAGAGAGAGCTCAACGGGTAC and
CCGTTGAGCTCTCTCTCGCG, to yield pSPB3L
1. In this plasmid, the segment
encoding amino acid residues 366-383 of the
1B subunit were deleted.
B3L
2, B3L
3, and B3L
4--
The plasmid pSPB3 was
digested with SacI, blunted with T4 DNA
polymerase, and cleaved with NotI, PvuII,
XmnI, and/or PflMI. The 1.1-kb
NotI/SacI and 510-bp
PvuII/PflMI fragments, the 1.2-kb NotI/PvuII and 360-bp
XmnI/PflMI fragments, and the 1.1-kb
NotI/SacI and 360-bp
XmnI/PflMI fragments were ligated with the 8.6-kb
NotI/PflMI fragment from pSPB3S to produce
pSPB3L
2, pSPB3L
3, and pSPB3L
4, respectively. In the plasmid
pSPB3L
2, the segment encoding amino acid residues 384-420 of the
1B subunit was deleted. In the plasmid pSPB3L
3, the
segment encoding amino acid residues 421-470 of the
1B
subunit was deleted, and the codon ATG for Met-471 was replaced with
the codon GTG for (Val). In the plasmid pSPB3L
4, the segment
encoding amino acid residues 384-470 of the
1B subunit was deleted, and the codon ATG for Met-471 was replaced with the codon
GTG for (Val).
B1T
1--
pSPCBI-1 (20) was digested with HindIII
or SphI, blunted with T4 DNA polymerase, and digested with
SalI. The resulting 5.6-kb SalI/SphI
(blunted) and 3.6-kb HindIII (blunted)/SalI
fragments were ligated to yield pSPBIC
1 (originally pSPCBI
SH-1).
In the plasmid pSPBIC
1, the segment encoding amino acid residues
1856-2273 of the
1A (BI-1
1) subunit was
deleted, and the amino acid residues AFRLRAAERGR were attached.
B1T
2--
Oligonucleotides
GATCTATGCCGCCATGATGATCATGGAGTACTAC,
CGGCAGAGCAAAGCCAAAAAGCTGCAGGCCATGCGCGAGGAG,
CAGAACCGGACACCGCTCATGTTCCAGCGCATGGAGCCCCCG, and
CCGGATGAGGGGGGCGCCGGCCAGAACGCCCTGCCCTAGCGC were annealed with GGCCGCGCTAGGGCAGGGCGTTCTGGCCGGCGCCCCCCTC,
ATCCGGCGGGGGCTCCATGCGCTGGAACATGAGCGGTGTCCG, GTTCTGCTCCTCGCGCATGGCCTGCAGCTTTTTGGCTTTGCT, and
CTGCCGGTAGTACTCCATGATCATCATGGCGGCATA, respectively, ligated, and
cleaved with BglII and NotI. The resulting 170-bp
BglII/NotI fragment was ligated with the 5.8-kb
XbaI/NheI, 2.6-kb
NheI/BglII, and 1.1-kb
NotI/XbaI fragment from pSPCBI-1 to yield
pSPBIC
4. The plasmid carries cDNA encoding the
1A
(BI-1
1) subunit with a deletion of the C-terminal amino
acid residues 2015-2273.
CDB1--
The 640-bp BamHI/BstXI and
420-bp BstXI/XmnI fragments from pCARD3 (18), the
87-bp XmnI/HindIII fragment from pSPCBI-2 (20), and the HindIII/BamHI 2.4-kb fragment from pSP72
were ligated to yield pCB(Bm-Hd). The 1.5-kb
XhoI/BamHI fragment from pCARD3, the 1.1-kb
BamHI/HindIII fragment from pCB(Bm-Hd), and the
9.3-kb HindIII/SalI fragment from pSPCBI-2 were
ligated to yield pBC2. In the plasmid pBC2, the
1A (BI-2
1) subunit cDNA has a substitution of the nucleotide
sequence encoding residues 1-777 of the
1C subunit for
the sequence encoding the amino acid residues 1-707.
CDTB1--
The 7.2-kb XbaI/PflMI fragment
from pCARD3, the 3.1-kb SphI/XbaI fragment
from pSPCBI-2, and the annealed oligonucleotides CTGGATGAATACGTGCGGGTCTGGGCCGAGTACGACCCTGCTGCTTGGGGACGCATG and CGTCCCCAAGCAGCAGGGTCGTACTCGGCCCAGACCCGCACGTATTCATCCAGATG were ligated to yield pBC4. The plasmid pBC4 carries cDNA for the
1C subunit which has the C-terminal tail residues
1524-2127 replaced with the tail residues 1838-2424 of the
1A (BI-2
1) subunit.
Subcloning and mutagenesis procedures were verified by restriction
enzyme analysis and DNA sequencing.
Functional Expression of Wild-type, Mutant, and Chimeric
Ca2+ Channels in Xenopus Oocytes
After removal of the follicular cell layer (15),
Xenopus oocytes were injected either with 0.3 µg/µl
1 (
1B,
1A,
1C, mutant
1, or chimeric
1) cRNA in combination with 0.2 µg/µl
2 cRNA and 0.1 µg/µl
1a cRNA; 0.03 µg/µl DOR cRNA; 0.05 µg/µl Gi3
cRNA, or 0.05 µg/µl G
1 cRNA, and 0.025 µg/µl G
2
cRNA, unless otherwise specified. The average volume of injection was
~50 nl per oocyte. The injected oocytes were incubated for 3-5 days
and then subjected to electrophysiological measurements at 21 ± 2 °C.
In order to unmask the effect of endogenous G
(16), a
deoxyoligonucleotide 20-mer (AGO) of the following sequence was used in
antisense experiments, CATGACTGCTCGGGGGGGGA. The AGO antisense oligonucleotide is complementary to nucleotides (
17 to 3) of the
Xenopus Go
mRNA (23). The endogenous
Xenopus Go
nucleotide sequence shows 40%
identity with the corresponding nucleotide sequence of
Go
cRNA injected. This antisense oligonucleotide (0.1 µg/µl, 50 nl) was injected 12-16 h prior to electrophysiological measurements.
The oocytes were positioned in a recording chamber (1.0 ml in volume)
and were perfused with a Ba2+ solution containing 40 mM Ba2+, 50 mM Na+, 2 mM K+, and 5 mM HEPES (pH 7.5 with
methanesulfonic acid). Membrane currents through the expressed
Ca2+ channels were measured with the two-microelectrode
voltage-clamp method as described previously (15). Also, the membrane
potential recorded by the potential electrode was monitored. The
membrane was held at
80 or
100 mV, and step depolarizations were
applied to activate the Ca2+ channels. Microelectrodes were
filled with 3 M KCl, and those showing resistances of
0.5-1.5 megohms were used.
We noticed slow tail currents upon repolarization as shown in Fig. 1.
In these cases, the time resolution of clamping was within 4 ms and the
potential error was within 3% of the command pulse, indicating no
serious space-clamping problems in characterizing Ca2+
channel currents.
Unless otherwise stated, statistical data were represented by the mean
and S.E.
 |
RESULTS |
Functional Expression of the N-, P/Q-, and L-type Ca2+
Channels in Xenopus Oocytes--
To establish a recombinant expression
system, where current inhibition mediated by G-proteins can be
reconstituted individually, HVA N-, P/Q-, and L-type Ca2+
channels were co-expressed in Xenopus oocytes by injection
of cRNAs for three (
1,
2, and
1) Ca2+ channel subunits and the
-opioid
receptor (DOR). Their responses to the opioid peptide, Leu-enkephalin
(Leu-EK), were examined by the two-microelectrode voltage-clamp
technique.
Fig. 1 illustrates inward membrane
currents recorded from Xenopus oocytes that were injected
with the N-type
1B (Fig. 1, A and
B), P/Q-type
1A (Fig. 1, C and
D), and L-type
1C (Fig. 1, E and
F) cRNA in combination with
2 and
1a subunits and DOR. As shown by the current-voltage
(I-V) relationships in Fig. 1, step depolarizations from a
holding potential of
80 mV produced long lasting inward currents at
potentials more positive than
30 mV for oocytes injected with
1B (Fig. 1B) and
1A subunits (Fig. 1D) and at potentials positive to
50 mV with
1C (Fig. 1F).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 1.
Functional expression of N-
( 1B), P/Q- ( 1A), and L-type
( 1C) Ca2+ channels in Xenopus
oocytes. Membrane currents were recorded from oocytes injected
with cRNA for one of three kinds of Ca2+ channel
1 subunits ( 1B (A and
B), 1A (C and D), and
1C (E and F)) in combination with
cRNAs for Ca2+ channel 2 and
1a subunits and cRNA for DOR. The external solution
contained 40 mM Ba2+. A,
C, and E; B, D, and F,
left, inward Ba2+ currents induced by step
depolarizations (250 or 300 ms in duration) from a holding potential of
80 mV to +10 mV. The records were taken before (A,
C, and E; control; B,
D, and F; line 1) and 20 s after
application of 0.1 or 1 µM -CTx (A), 0.3 µM -Aga (C), 10 µM nifedipine
(E), or 1 µM Leu-EK (B,
D, and F; line 2), and 10 min after removal
of Leu-EK (B, D and F; line
3). B, D, and F, right,
current-voltage (I-V) relationships for the records shown in
B, D, and F, left. The
membranes were held at 80 mV and depolarized by a 250 (or 300)-ms
test pulse from 80 mV to +50 mV with 10 mV steps. Peak currents
before (open circles) and during (filled circles)
exposure to 1 µM Leu-EK and after removal of Leu-EK
(filled triangles) are plotted against the membrane
potential of test pulses. Note that the peak current is inhibited
prominently by Leu-EK either in B or D.
Therefore, in the following experiments, the amplitude of peak currents
was used as a measure of the response to Leu-EK. In practice, peak
currents were measured before and after application of a receptor
agonist, and the change was expressed as their ratio.
|
|
As shown in Fig. 1A, inward currents recorded from oocytes
implanted with
1B,
2,
1a
and DOR showed a time-dependent inactivation and a
sensitivity to 0.1 µM
-conotoxin GVIA (
-CTx), an
N-type Ca2+ channel blocker. This current was not blocked
by 0.3 µM
-agatoxin IVA (
-Aga), a P/Q-type
Ca2+ channel blocker (n = 3), nor 10 µM nifedipine, a dihydropyridine (DHP)-derivative L-type
Ca2+ channel blocker (n = 12). Application
of Leu-EK (1 µM) to the bathing solution inhibited inward
current from N-type channels within seconds (Fig. 1B). The
inhibited current displayed "kinetic slowing" of the current
activation as well as an overall reduction in peak current (24,
25).
As shown in Fig. 1, C and D, oocytes expressing
1A,
2,
1a, and DOR
exhibited inward currents which were blocked by 0.3 µM
-Aga (Fig. 1C) but not by 0.3 µM
-CTx
(n = 3) nor 10 µM nifedipine (n = 9), consistent with previous findings. Application
of Leu-EK to oocytes expressing
1A also displayed
Ca2+ channel modulation, similar to that observed with
1B. Since DOR translates a signal to downstream
effectors through activation of G-proteins (26), it is conceivable that
the Leu-EK-induced inhibition of
1B and
1A currents is mediated by endogenous oocyte G-proteins.
Following the injection of L-type
1C cRNA in combination
with
2,
1a, and DOR cRNAs, inward
currents were observed (Fig. 1, E and F), which
were sensitive to 10 µM nifedipine (Fig. 1E) (18), but were not blocked by 0.3 µM
-CTx
(n = 3) nor 0.3 µM
-Aga
(n = 3). By contrast to the
-CTx-sensitive N-type or
-Aga-sensitive P/Q-type currents, these currents were not inhibited
by Leu-EK (Fig. 1F).
Thus, based on the electrophysiological and pharmacological properties,
1B,
1A, and
1C channels
functionally expressed in oocytes possessed the native characteristics
of
-CTx-sensitive N-type,
-Aga-sensitive P/Q-type, and
DHP-sensitive L-type Ca2+ channels, respectively. The
Leu-EK-induced inhibition of inward Ba2+ currents was not
appreciably observed when either DOR (n = 6) or the
1 subunit of Ca2+ channel (n = 6) cRNA was injected alone. In addition,
-CTx- (n = 13),
-Aga- (n = 3), and DHP (n = 15)-sensitive Ba2+ currents were not detectable without
injection of
1B,
1A, and
1C subunit cRNAs.
Effects of G
and G
on the N- and P/Q-type Ca2+
Channels--
To determine which arm of the G-protein complex
contributes to regulation of N- and P/Q-type Ca2+ channels,
either Gi3
cRNA or G
1 plus
G
2 cRNAs were injected into oocytes in combination with
Ca2+ channel
1 (
1B or
1A),
2, and
1a subunits
cRNAs and DOR cRNA.
As detailed in the companion paper (16), agonist-induced inhibition of
N-type
1B currents (Figs.
2A and 3A,
B3) and P/Q-type
1A currents (Fig. 4,
A and C, B1) was further pronounced in
oocytes injected with Gi3
cRNA. By contrast, inhibition
of
1B and
1A channels was not potentiated
in oocytes co-expressed with G
1
2. However, Ba2+ currents recorded from oocytes expressed with
Ca2+ channel
1B,
2, and
1a subunits, DOR and G
1
2,
were increased by a large conditioning depolarization to +80 mV without
receptor stimulation (Fig. 3A,
B3, open bar; also see Fig. 2 in the companion paper). This may indicate that the exogenous G
can inhibit the N-type Ca2+ channel by itself, therefore not requiring
receptor-mediated activation of G-proteins. Prepulse facilitations were
not prominent, but still significant, for the
1A channel
when injected with G
(Fig.
4C, B1). Moreover,
L-type
1C currents were never inhibited by the
application of agonist nor facilitated by administration of a prepulse
(Figs. 2A and 3A, CD).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 2.
Multiple structural domains in
1B channels for the inhibition mediated by
Gi3 and G 1 2. A,
left, schematic representation of mutant 1B and
1C channels and chimeric channels composed of
1B (hatched boxes) and 1C
sequences (open boxes). Deletion or replacement of the C
terminus and/or substitution of the intracellular loop between segment
I and II (loop 1) were carried out in the two types of 1
subunit of Ca2+ channels. Nomenclature is as follows:
B3, wild-type 1B; CD, wild-type
1C; T or Tail, C terminus;
L or L1, loop 1; , deletion. Functional
expression of Ca2+ channels is also indicated (+ and ).
A, right, responsiveness of mutant and chimeric
1 channels to 1 µM Leu-EK in oocytes
implanted with DOR, 1, 2, and
1a in combination with Gi3 (filled
boxes), G 1 2 (hatched
boxes), or no exogenous G-protein (open boxes).
Positive and negative responses represent inhibition and facilitation
of channels, respectively. In oocytes from which endogenous
Ca2+ currents were recorded, 1 subunit was
not co-expressed (No exogenous Ca2+
channel). In other oocytes, wild-type, mutant, and chimeric
1 subunits as indicated for each on the left
side were co-expressed. The antisense oligonucleotide, AGO, was
used. The responses to Leu-EK were measured (see Fig. 1 legend) and
expressed as ratios of inhibition. The number of oocytes examined for
each data are 4-68. B, representative current traces for
the mutant 1B (B3T 1) and 1C (CDT 1)
channels and the chimeric 1B/ 1C (B3LCD,
B3LCDT 1, CDTB3, CDLB3, and CDLB3TB3) channels in oocytes
co-expressed with DOR, Gi3 , and Ca2+ channel
2 and 1a subunits. The pulse protocol was
identical to that in Fig. 1 for 1B channels.
Concentrations of Leu-EK, -CTx, and nifedipine used were 1, 0.3, and
10 µM, respectively. The antisense oligonucleotide, AGO,
was used.
|
|

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 3.
The C terminus and the loop 1 of
1B channels determining the interactions with
Gi3 and G 1 2. A
and B, upper, comparisons of wild-type, mutant,
and chimeric 1B and 1C channels with
respect to the Leu-EK-induced inhibition via Gi3 and to
the prepulse facilitation via G 1 2. The
responses of 7 different channel types, as indicated with schemes, to 1 µM Leu-EK (horizontal bars), prepulse
(open circles), or both (filled circles) were
measured in oocytes co-expressing with DOR, 2, and
1a in combination with G-protein subunit as indicated.
The pulse protocols were as follows: a 200-ms test pulse was applied to
+10 mV from a holding potential of 100 mV, which was preceded, if
necessary, by a depolarizing prepulse (30 ms in duration) to +80 mV and
then by a 20-ms repolarization to 100 mV. The antisense
oligonucleotide, AGO, was used. The number of oocytes examined for each
data are 4-23 in A and 4-10 in B. The deletion
sites for these mutant 1B channels in B are
represented schematically in Fig. 5A. A and
B, lower, Leu-EK-induced inhibition as mediated
by Gi3 (filled bars) and prepulse-induced
facilitation as mediated by G 1 2
(open bars). Differences in the response to Leu-EK between
oocytes with and without expression of Gi3 and changes
induced by prepulse without Leu-EK in oocytes expressing
G 1 2, as shown in upper, are
represented as Response.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 4.
Regulation of P/Q-type ( 1A)
channels by G and G . A, left, schematic
representation of mutant 1A channels and chimeric
channels composed of 1A (filled boxes) and
1C sequences (open boxes). Nomenclature is
given in the legend of Fig. 2A, except that B1
denotes wild-type 1A. Functional expression of
Ca2+ channels is also indicated (+ and ). A,
right, responsiveness of mutant 1A and
chimeric 1A/ 1C channels to 1 µM Leu-EK in oocytes implanted with DOR,
1, 2, and 1a in
combination with Gi3 (filled boxes),
G 1 2 (hatched boxes), or no
exogenous G-protein (open boxes). In oocytes from which
endogenous Ca2+ currents were recorded, 1
subunit was not co-expressed (No exogenous
Ca2+ channel). In other oocytes, wild-type,
mutant, and chimeric 1 subunits as indicated for each on
the left side were co-expressed. The antisense
oligonucleotide, AGO, was used. The responses to Leu-EK were measured
(see Fig. 2A) and expressed as ratios. The number of oocytes
examined for each data are 4-18. B, representative current
traces for the mutant (B1T 2) and chimeric (CDTB1) 1A
channels in oocytes implanted with DOR, Gi3 ,
2, and 1a in combination with each mutant
or chimeric 1. The pulse protocol was identical to that
as in Fig. 1 for the 1A channel. Concentrations of
Leu-EK and nifedipine used were 1 and 10 µM,
respectively. The antisense oligonucleotide, AGO, was used.
C, comparisons of wild-type, mutant, and chimeric
1A channels with respect to the Leu-EK-induced
inhibition via Gi3 and to the prepulse facilitation via
G 1 2. The responses of three different
channel types, as indicated, to 1 µM Leu-EK
(horizontal bars), prepulse (open circles), or
both (filled circles) were measured (see Fig. 3A)
and expressed as ratios. The antisense oligonucleotide, AGO, was used.
The number of oocytes examined for each data are 4-18.
|
|
Combination of
1B,
2, and
1a Subunits Is Required for the Inhibitory Regulations
by Gi3
and G
--
The
1 subunit of
the Ca2+ channel forms the channel pore (4). As a result of
this, N-type Ca2+ channel currents were not detectable
without the injection of
1B subunit cRNA
(n = 13). However, when the
1B subunit
was expressed without the
2 and
1a
subunits, Leu-EK still produced channel inhibition and slowing of the
1B currents via Gi3
(n = 8). Moreover, the opioid-induced inhibition of
1B
currents was larger in the absence of
1a subunit
(n = 15) and did not change without the
2 subunit (n = 8) (27, 28). In addition,
the prepulse facilitation of
1B currents mediated via
G
1
2 (see Fig. 3) was also present without
the
2 and
1a subunits (n = 5). These results suggest that both G
and G
can interact
with the
1 subunit regardless of subunit composition and
are able to produce channel modulation.
Interaction of G
and G
with Mutant and Chimeric
1B Channels--
By aiming at identifying the regions
on the
1B channel interacting with Gi3
and G
1
2, chimeric channels between
1B (Fig. 2A, B3) and
1C (Fig. 2A, CD) were constructed.
These constructs were generated (Fig. 2), taking advantage of the
inability of
1C channels to be inhibited by G-proteins
(Figs. 1F, 2A, and 3A). Neither a
deletion of the C-terminal region of
1B (amino acid
residues 1913-2339, see Fig. 5) nor a
replacement of the C-terminal region of
1B (amino acid
residues 1912-2339) by that of
1C (amino acid residues
1658-2171) affected the Leu-EK-induced inhibition of Ca2+
channels in oocytes co-expressed with Gi3
and
G
1
2 (Fig. 2, A and
B; B3T
1 and B3TCD, respectively).
Moreover, currents through the chimeric
1B channel,
B3LCD, in which a region of
1C (amino acid residues
411-740) containing the intracellular loop joining motif I and II
(loop 1) was substituted for that of
1B (amino acid
residues 332-668), were inhibited by Leu-EK in oocytes co-expressed with G
or G
(Fig. 2, A and B,
B3LCD). However, a deletion of the C-terminal region of
B3LCD (corresponding to amino acid residues 1913-2339 of
1B) produced a chimeric channel, B3LCDT
1, which was
insensitive to Leu-EK (Fig. 2, A and B,
B3LCDT
1).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 5.
Schematic representation of the sites on
1B subunit for making the deletion mutants.
A, positions of the deletion (L 1, L 2, L 3, and
T 1), the loop 1, and the C terminus are indicated by the number of
the amino acid residues for 1B subunit (33) and
1A (BI-1 1) subunit (20) in parentheses.
The deletion sites are indicated by the crossing bars, and
the cytoplasmic side below the horizontal lines. The
asterisk denotes the binding site for Ca2+
channel subunit (31), and the filled circle denotes the
phosphorylation sites for protein kinase C (10). B,
mutations introduced into the 1B and 1A
subunits. The numbers of amino acid residues deleted are
indicated.
|
|
On the other hand, chimeric
1C channels such as CDTB3,
CDLB3, and CDLB3TB3, in which the C-terminal region of
1C (amino acid residues 1658-2171), the region of
1C containing loop 1 (amino acid residues 318-610), or
both, were replaced by the corresponding region(s) of
1B
(amino acid residues 1912-2339, 242-537, or both, respectively),
gained sensitivities to Leu-EK (Fig. 2, A and B, CDTB3, CDLB3, and CDLB3TB3).
The mutant and chimeric
1B (Fig. 2B,
B3T
1, B3LCD, and B3LCDT
1;
n = 5) and
1C channels (Fig.
2B; CDT
1, CDTB3; n = 5) were sensitive to
-CTx and nifedipine, respectively, as
expected from earlier studies locating interaction sites of both
-CTx (29) and DHPs (30). In addition, deletion of the C-terminal
region of
1C (amino acid residues 1981-2171) produced a
mutant channel, CDT
1, whose activities were rather enhanced by
Leu-EK, when Gi3
or G
1
2
was co-expressed (Fig. 2, A and B).
Effects of Prepulse on the Inhibitions of Mutant and Chimeric
N-type Ca2+ Channels via Gi3
or
G
1
2--
The experiments described
above, in which the wild-type
1B and
1A
channels were used, demonstrated that G
plays a significant role in
G-protein-mediated inhibition of neuronal Ca2+ channels.
However, there is a possibility that G
exerts its effect indirectly
upon Ca2+ channels through G
. To exclude this
possibility, it was necessary to investigate further molecularly and
structurally the dependence of G
on G
when interacting with
Ca2+ channel
1 subunits.
In order to clarify further the modulation sites on the
1B channel by Gi3
and
G
1
2, responses to Leu-EK and a large
prepulse were studied in oocytes implanted with mutant and chimeric
Ca2+ channel
1,
2, and
1a subunits, DOR, and Gi3
(or
G
1
2) (Fig. 3). For clarity, changes
induced by application of a prepulse without Leu-EK, in oocytes
expressing G
1
2, and differences in the
response to Leu-EK between oocytes with and without expression of
Gi3
, are summarized in Fig. 3 (
Response).
In the case of wild-type
1B channels, co-expressed with
G
1
2, a remarkable prepulse facilitation
was observed in the absence of Leu-EK (Fig. 3A,
B3, open bar), whereas the
1B
chimera, B3LCD (having a loop 1 region derived from
1C),
when co-expressed with G
1
2, displayed a
complete loss of prepulse facilitation (Fig. 3A,
B3LCD, open bar). By contrast, the
1C chimera, CDLB3 (having a loop 1 region derived from
1B), restored the prepulse facilitation when
G
1
2 was co-expressed (Fig. 3A,
CDLB3, open bar). Moreover, deletion of the C
terminus of
1B enhanced the prepulse facilitation in oocytes co-expressed with G
1
2 (Fig.
3A, B3T
1, open bar).
When Gi3
, instead of G
1
2,
was co-expressed, the agonist-induced inhibition of Ca2+
currents was strengthened in wild-type
1B channels as
compared with control oocytes, in which no exogenous G-proteins were
co-expressed (Fig. 3A, B3, filled
bar). This large inhibition was abolished by applying a large
conditioning prepulse (filled circle). In chimeric
1B channels, B3LCD, such a potentiation of current
inhibition by Gi3
was still detectable (Fig.
3A, B3LCD, filled bar) and almost
entirely relieved by applying a prepulse (filled circle). Furthermore, deletion of the C terminus of B3LCD abolished the sensitivity to the agonist-induced inhibition with Gi3
(Fig. 3A, B3LCDT
1, filled bar). By
contrast, the
1C chimera, CDTB3, having a C terminus
derived from
1B, acquired sensitivity to the
agonist-induced current inhibition with Gi3
(Fig.
3A, CDTB3, filled bar), but the
prepulse procedure failed to influence this inhibition (filled
circle). The deletion alone of the C terminus of
1B
channel did not affect the channel responsiveness to Gi3
(Fig. 3A, B3T
1, filled bar).
To gain a clearer understanding of contributions of loop 1 in more
detail, Ba2+ currents through mutant
1B
channels with four kinds of loop 1 deletions were studied (Fig.
3B). In the mutant channel, B3L
2, with a deletion of
amino acid residues 384-420 of
1B (Fig. 5A, L
2), the prepulse facilitation in oocytes co-expressed
with G
1
2 was diminished (Fig.
3B, B3L
2, open bar). However,
currents through the mutant channel, B3L
3, with a deletion of amino
acid residues 421-470 of
1B (Fig. 5A,
L
3), were facilitated by a prepulse when
G
1
2 was co-expressed (Fig. 3B,
B3L
3, open bar). In both mutant channels, the
potentiation by Gi3
of Leu-EK-induced inhibition of
currents was observed (filled bar). These characteristics of B3L
2 indicate that deletion of loop 1, which nearly abolished interaction of the
1B subunit with G
, did not
impair interactions with G
. On the other hand, we could not detect
expression (n = 6) of the mutants, B3L
1 and B3L
4,
in which either a part of the loop 1 of
1B (amino acid
residues 366-383, see Fig. 5A, L
1) or a part
of the loop 1 of
1B that combines the regions covered by
L
2 and L
3 (amino acid residues 384-470,
see Fig. 5A) were deleted. Moreover, currents through the
mutant channel, B3L
2, were not detectable in the absence of
Ca2+ channel
subunit expression (n = 5). Because B3L
2 was devoid of the segment corresponding to the
major binding site for the
subunit (31), this indicates that there
may be another interaction site on the
1B channel for
subunits (32).
Interaction Site on the P/Q-type Ca2+ Channel for
G-protein--
In order to determine the interaction site on the
P/Q-type Ca2+ channel for G
and G
, procedures
similar to those for
1B channels (Figs. 2 and 3) were
applied to
1A channels (Fig. 4). In oocytes co-expressed
with Gi3
or G
1
2 together
with DOR and Ca2+ channel (
1,
2 and
1a subunits), deletion of the C
terminus of
1A (amino acid residues 2015-2273) reduced
the sensitivity to Leu-EK (Fig. 4A, B1T
2) as
compared with the wild-type
1A (B1). This
stands clearly in contrast to the mutant
1B channel (B3T
1), in which deletion of the C terminus alone did not influence the sensitivity to Leu-EK (Fig. 2A). In addition, the
chimeric
1C channel (CDTB1), in which the C terminus of
1C (amino acid residues 1524-2127) was replaced by that
of
1A (amino acid residues 1838-2424), acquired
sensitivity to Leu-EK (Fig. 4A, CDTB1), whereas the wild-type
1C channel was not affected by Leu-EK
(Figs. 2A and 3A). Another chimeric
1C/
1A channel (CDB1), in which the N
terminus of
1C (amino acid residues 1-777) substituted
for that of
1A (amino acid residues 1-707), still
exerted sensitivities to Leu-EK (Fig. 4A, CDB1).
As shown in Fig. 4B, currents through the B1T
2 and CDTB1
channels were comparable to those through the wild-type
1A and
1C channels (Fig. 1), and the
CDTB1 currents were blocked by nifedipine.
Next, the mutant (B1T
2) and chimeric (CDTB1)
1A
channels were further characterized using a double-pulse protocol. Fig. 4C illustrates responses to application of a prepulse and
Leu-EK by these channels and also demonstrates changes induced by
prepulse without Leu-EK in oocytes expressing
G
1
2 as well as differences in the
response to Leu-EK between oocytes with and without expression of
Gi3
. The potentiation by Gi3
of
Leu-EK-induced inhibition observed in the wild-type
1A
(Fig. 4C, B1, filled bar) almost disappeared in the mutant
1A, B1T
2, having the
deletion of C terminus (Fig. 4C, B1T
2,
filled bar). By contrast, the
1C/
1A chimera, CDTB1 (having the C
terminus derived from
1A), conferred Leu-EK sensitivity
via Gi3
(Fig. 4C, CDTB1,
filled bar). In both the wild-type
1A and the
chimera CDTB1, the prepulse did not abolish the potentiation of
Leu-EK-induced inhibition via Gi3
(filled
circles). In addition, when G
1
2 was
co-expressed instead of Gi3
, a small facilitation by
prepulse was observed in the wild-type
1A (Fig.
4C). In the mutant (B1T
2) and chimera (CDTB1) channels,
prepulse facilitation was not detected.
 |
DISCUSSION |
In the present study, the
-CTx-sensitive N-type
(
1B) and
-Aga-sensitive P/Q-type (
1A)
Ca2+ channels were functionally expressed in
Xenopus oocytes, an in vivo expression system. As
described, we found that Gi3
co-expressed in oocytes
mediated receptor agonist-induced inhibition of N-type
1B and P/Q-type
1A channels. On the other
hand, a depolarizing prepulse relieved current inhibition caused by the
G
1
2 complex, and the facilitatory effects
were more pronounced in
1B than in
1A.
Because responsiveness of the
1B and
1A
channels to the inhibition mediated by Gi3
and
G
1
2 was maintained even in the absence of
the Ca2+ channel auxiliary subunits
2 and
1, the
1 subunit should bear the
interaction sites for both the G
subunit and the G
dimer. Finally, we defined loop 1 of
1B as an interaction site
for G
and the C termini of
1B and
1A for G
, based on the responses of mutant and
chimeric channels to G
and G
.
The Native Type
1B,
1A, and
1C Channels Expressed in Xenopus Oocytes--
The
electrophysiological and pharmacological properties of the
1B,
1A, and
1C channels
determined were identical to those of the N-, P/Q-, and L-type
Ca2+ channels described previously (18, 20, 33). This
indicates that
1B (N-type),
1A
(P/Q-type), and
1C (L-type) Ca2+ channels
were functionally expressed with the Ca2+ channel
2 and
1 subunits in Xenopus
oocytes. When DOR was further co-expressed, 